Sources | Names Used |
---|---|
CTRPv2 | doxorubicin:navitoclax (2:1 mol/mol) |
PharmacoGx | doxorubicin:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SETMAR | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-09 |
mRNA | C7orf26 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-09 |
mRNA | ZBTB5 | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-09 |
mRNA | DOPEY1 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-09 |
mRNA | ALMS1 | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-09 |
mRNA | SOX4 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-09 |
mRNA | ZNF618 | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-09 |
mRNA | BAHCC1 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-09 |
mRNA | TARBP1 | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-09 |
mRNA | TRIM13 | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-09 |